PIN6 CLINICAL BENEFITS AND COST SAVINGS FROM IMPLEMENTING A SIMPLIFIED STRATEGY FOR GLECAPREVIR/PIBRENTASVIR (G/P) 8-WEEK TREATMENT IN NON-CIRRHOTIC NAÃVE PATIENTS WITH HEPATITIS C. THE JUST SIMPLE STUDY (REAL CLINICAL PRACTICE IN SPAIN).
| Autor: | Turnes, J., Rincon Rodriguez, D., Calleja, J.L., Delgado, M., Rosales-Zabal, J.M., Andrade, R., Manzano Alonso, M.L., Salmeron Escobar, J., Lopez garrido, M.A., Calvo Sanchez, M., Gomez Camarero, J., Molina Perez, E., Olveira Martin, A. |
|---|---|
| Zdroj: | In Value in Health May 2020 23 Supplement 1:S169-S169 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect